# FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae

> **NCT05791396** · PHASE1,PHASE2 · RECRUITING · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS** · enrollment: 36 (estimated)

## Conditions studied

- Enterobacteriaceae Infections
- Multi-antibiotic Resistance

## Interventions

- **BIOLOGICAL:** Donor - FMT
- **OTHER:** Placebo FMT

## Key facts

- **NCT ID:** NCT05791396
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-08
- **Primary completion:** 2026-04
- **Final completion:** 2026-04
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2025-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05791396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05791396, "FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05791396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*